key: cord-1021050-7xba18ch
authors: Smallman-Raynor, M. R.; Cliff, A. D.; Consortium, The COVID-19 Genomics UK
title: Spatial Growth Rate of Emerging SARS-CoV-2 Lineages in England, September 2020-December 2021
date: 2022-02-02
journal: nan
DOI: 10.1101/2022.02.02.22270110
sha: 37f4d17add1fbb62665d693a74e3bba26f8dad55
doc_id: 1021050
cord_uid: 7xba18ch

This paper uses a robust method of spatial epidemiological analysis to assess the spatial growth rate of multiple lineages of SARS-CoV-2 in the local authority areas of England, September 2020-December 2021. Using the genomic surveillance records of the COVID-19 Genomics UK (COG-UK) Consortium, the analysis identifies a substantial (7.6-fold) difference in the average rate of spatial growth of 37 sample lineages, from the slowest (Delta AY.4.3) to the fastest (Omicron BA.1). Spatial growth of the Omicron (B.1.1.529 and BA) variant was found to be 2.81x faster than the Delta (B.1.617.2 and AY) variant and 3.76x faster than the Alpha (B.1.1.7 and Q) variant. In addition to AY.4.2 (a designated variant under investigation, VUI-21OCT-01), three Delta sublineages (AY.43, AY.98 and AY.120) were found to display a statistically faster rate of spatial growth than the parent lineage and would seem to merit further investigation. We suggest that the monitoring of spatial growth rates is a potentially valuable adjunct to routine assessments of the growth of emerging SARS-CoV-2 lineages in a defined population.

Emerging lineages of the severe acute respiratory syndrome coronavirus 2 (SARS- have the potential to place significant pressure on public health systems due to increased infectivity, transmissibility, virulence, immune escape or other fitness advantage [1, 2] .

Global genomic surveillance has identified >1,700 SARS-CoV-2 lineages since the beginning of the COVID-19 pandemic [3, 4] One important epidemiological facet of an emerging SARS-CoV-2 lineage is its propensity to grow in a defined population [9] . There are well-established methods for assessing the rate of temporal growth by, for example, examining the trajectory of case doubling times or estimating the basic reproduction number, 0 , of the agent in question [10, 11] . Viewed from a geographical perspective, these measures are essentially aspatial in that they provide very little information on the geographical growth, or spatial expansion, of the associated infection wave. To extend the examination of SARS-CoV-2 growth rates into the spatial domain, the present paper applies a robust method of spatial epidemiological analysis that is known as the swash-backwash model of the single epidemic wave [12] to the genomic surveillance records of the COVID-19 Genomics UK (COG-UK) Consortium [13] . Using the spatial sequence of detection of sample variants as a proxy for the spatial wave front of infection, our examination yields estimates of the spatial growth rate of multiple SARS-CoV-2 lineages in the local authority areas of England, September 2020-December 2021.

For a total of 37 sample lineages under investigation, we present evidence of a substantial (7.6-fold) difference in the average rate of spatial growth, from the slowest (Delta AY.4.3) to the fastest (Omicron BA.1). Whilst the overall results for the Alpha, Delta and Omicron variants are consistent with the documented growth advantages for these lineages, several emergent Delta sublineages (AY.4.2, AY.43, AY.98 and AY.120) are found to have had a statistically significant growth advantage over the parent lineage. To our knowledge, this is the first comparative study of the spatial growth rate of multiple emerging SARS-CoV-2 lineages at the national level. It is also the first report of a spatial growth advantage for the Delta AY.43, AY.98 and AY.120 lineages, and the first to document an apparently reduced spatial growth rate for a substantial number of other AY lineages that emerged in the spring and summer of 2021. We suggest that the monitoring of spatial growth rates is a potentially valuable adjunct to routine assessments of the growth of SARS-CoV-2 lineages in a defined population.

Since September 2020, successive waves of SARS-CoV-2 infection with emerging lineages of the Alpha (September 2020 onset), Delta (March 2021 onset) and Omicron (November 2021 onset) variants have been recorded in England [14] [15] [16] . The weekly record of COVID-19 cases to mid-December 2021 is plotted in Figure 1A , whilst the underpinning sequence of variants is depicted in Figure 1B . As Figure 1B shows, Alpha, Delta and Omicron achieved the status of dominant variants in December 2020, May 2021 and December 2021, respectively.

We draw on the integrated national-level SARS-CoV-2 genomic surveillance records of the COVID-19 Genomics UK (COG-UK) Consortium [13] . Lineage counts by local authority area and week of sample collection for England were accessed from the COG-UK website is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint (Table 1) . Samples belonging to these lineages form the basis of all our analysis.

To assess the spatial growth rate of a given SARS-CoV-2 lineage, we draw on the swashbackwash model of the single epidemic wave [12] . In essence, the model represents a spatial derivative of the generic SIR mass action models of infectious disease transmission [19] . 

Full details of the modelling procedure are outlined by Cliff and Haggett [12] . For the purposes of the present analysis, we focus on the spatial expansion phase (that is, the change of state from S to I across a set geographical units) for a given SARS-CoV-2 lineage.

Specifically, let the first week in which the lineage was detected in England be coded as t = 1. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 2, 2022. (1)

Here, is the number of units whose leading edge, LE, occurred in week t and = ∑ . Table 1 . Table 1 

The upper graphs in Figure where weeks are indexed to the earliest detection of the respective variants ( Table 1) . The lower graphs are spatial growth curves, formed by replotting the information in the upper graphs as a cumulative proportion of LTLAs. Average curves for the set of sample lineages in Table 1 are shown for reference.

Together, the graphs in Figure is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 2, 2022. ; https://doi.org/10.1101/2022.02.02.22270110 doi: medRxiv preprint sequentially shorter periods to earliest detection ( Figure 3 ). The latter feature is emphasized when earliest detections are formed as regional averages in Figure 4 .

The right-hand column in Table 1 summarizes the results of the application of equation (1) to each of the sample lineages. Computed values of ̅ and associated 95% confidence intervals (95% CI) are given, along with an overall average value of ̅ for the entire sample. As noted above, lineages with relatively high rates of spatial expansion (or rapidly developing is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint There is a 7.6-fold difference in the range of values of ̅ in Figure 5 , from Delta AY.4.3 with the lowest spatial growth rate (19.93 weeks) to Omicron with the highest (2.63 weeks). A group of four AY lineages (AY.4.2, AY.43, AY.98 and AY.120), first detected in the period from mid-May to mid-July 2021, are positioned between Delta and Omicron in Figure 5 and display rates of spatial growth that are significantly higher (as judged by 95% CI) than the aggregate rate for the Delta variant. In contrast, the overwhelming majority of AY lineages display statistically lowerin many instances substantially lowerspatial growth rates (as judged by 95% CI) than the aggregate rate for the Delta variant. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint (AY.120) of the local authority areas under investigation, and each had been associated with considerably more than 10,000 detections (Table 1) . Table 2 summarizes the global status of these four lineages as of 9 January 2022. With the exception of the AY.43 lineage, which was prevalent in a number of European countries and associated with >267,000 detections worldwide, the majority of detections of these lineages originated from the United Kingdom. (Table 2 ) and would seem to merit further investigation on the basis of the findings presented here.

With the foregoing exceptions, our analysis has shown that many emerging AY lineages in England in the spring and summer of 2021 were associated with spatial growth rates that were lower (in some instances, substantially lower) than the aggregate rate for the Delta variant (Table 1 and Figure 5 ). Multiple biological (e.g. reduced infectivity or . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 2, 2022. ; https://doi.org/10.1101/2022.02.02.22270110 doi: medRxiv preprint transmissibility) and contextual (e.g. progressive expansion of the national COVID-19 vaccination programme) factors may account for this observation. Importantly, there is no evidence of a temporal trend in the observed rates of spatial growth that would be suggestive of either (i) a biological selection pressure in favour of a growth advantage of emerging lineages or (ii) a progressive contextual effect in the form of, for example, increasing levels of vaccination coverage or natural immunity that would serve to retard growth rates.

Our estimates of ̅ in Table 1 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 2, 2022. Table 1 in the weeks to December 2021.

We have demonstrated, for the first time, a robust method for assessing and comparing the rate of spatial growth of multiple SARS-CoV-2 lineages in a set of geographical areas. We suggest that this approach represents a potentially valuable adjunct to routine assessments of the growth of emerging SARS-CoV-2 lineages in a defined population.

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 2, 2022. ; https://doi.org/10.1101/2022.02.02.22270110 doi: medRxiv preprint

None.

The data that support the findings of this study are available at Wellcome Sanger Institute COVID-19 Genomic Surveillance (https://covid19.sanger.ac.uk/lineages/raw). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 2, 2022. ; https://doi.org/10.1101/2022.02.02.22270110 doi: medRxiv preprint Table 1 . Estimated rate of spatial growth ( ̅ ) of sample SARS-CoV-2 lineages in England, September 2020-December 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 2, 2022. ; https://doi.org/10.1101/2022.02.02.22270110 doi: medRxiv preprint Figure 2 , with the average curve plotted for reference. Lineages are ordered according to the values of ̅ in Table 1 and are defined as having relatively high (i.e. low values of ̅ ; upper graphs, A) and relatively low (i.e. high values of ̅ ; lower graphs, B) rates of spatial growth.

Emerging SARS-CoV-2 variants: Genetic variability and clinical implications

Why are some coronavirus variants more infectious?

Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool

SARS-CoV-2 Variants of Concern and Variants under Investigation in England Technical Briefing 33. London: UK Health Security Agency

A swash-backwash model of the single epidemic wave

COG-UK) Consortium (2020) An integrated national scale SARS-CoV-2 genomic surveillance network

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Changing composition of SARS-CoV-2 lineages and rise of

Delta (B.1.617.2 and AY) and Omicron (B.1.1529 and BA) variants in England

LTLAs in which each of the three variants was first detected. The horizontal (time) axes are indexed to the epidemiological week of first detection (t = 1) of the corresponding variant. Average curves